Forethical reasonsthetreatment codeswerebrokenafter
allocation so that a thorough explanation of the use of disulfiram and the associated risks of drinking, to include written information and a pocket warning card, could be given to the patients and families concerned. If left blind, patients might have been tempted to test whether or not drinking could trigger a reaction. (Chick eta!, 1981)) wererepeatedafter one, threeand six months of treatment.
The vitaminC group was includedto control for the
Each centre appointed as an independent assessor to obtain follow-up data someone with previous experience with alcoholics: medical practitioners, nurses, or trained research interviewers. They were to stay blind to the â€˜¿ Typical week's consumption' was according to a retro spective diary of a typical week during which the patient drank. In addition, at each interviewthe assessor obtained an estimateof total consumptionin the previousfour weeks. These were aggregated in the analysis to give â€˜¿ total units consumed in past six months'. At intake the assessor had obtainedan estimateof the priorsix months' consumption, with anchor dates to aid memory. Informants'information was included, and was evaluated by the assessor in making a judgement, because patients are known to report less consumption than informants (Fuller et a!, 1988).
Statistical analysis
All data were used, on an â€˜¿ intention-to-treat' basis, irrespective of patient compliance, attempts having been madeto follow up all patients.Categorical datawereanalysed using Fisher's exact test for 2 x 2 tables and Pearson's x2 test for larger tables. Otherwise, the Mack-Skilling's test (Mack & Skillings, 1980) , taking account of the weighting at different centres, was used to test for significant treatment differences. Laboratory blood data were analysed by fitting anadditivelinearmodelof centreandtreatment effectsand using a (-test to compare treatments (Searle, 1971) .
Where possible, differences from pre-treatment were analysed.All tests weretwo-tailedwith a significancelevel of 5%.
Results

Thetwo groupsof patientscommencingtreatment (64 on
disulfiram, 62 on vitamin C) had similar demographic and social backgrounds. The overall mean age was 43 years (range 18-67); 84% were male, 65% were unemployed, and 46% lived with a spouse or other cohabitee. The commonest illnesssufferedwasgastrointestinal disease(21%of patients), of which85%wasalcohol-related. Two-thirds of thedisulfiram groupand halfthe vitaminC grouphad had in-patienttreat ment for alcoholism. Informantsweremainlyspouses(4l%) or members of the clinic staff (33%).
Fifty-sevenpatients(28on disulfiram, 29 on vitaminC)
did not adhere to their allocated treatment, 45 through failure to keep appointments or by withdrawing consent. Follow-upinterviewswerenot obtainedin 20%(15disulfiram patients, 14vitaminC patients).Both initialand final blood samples were available in only 57%, because at follow-up some patients were interviewedby telephone, and at intake and follow-up some samples were not analysable because of delay or damage. Four patients on disulfiram and one on vitamin C were withdrawnwith adversereactions:two of the formerowing to allergicskin rash,one withsuspectedneuropathy,and one with dizziness and nausea, while the patient on vitamin C was admitted suffering left hemiparesis. A further two withdrawals from the vitamin C group were due to increasing problemswith drinking.(Four of the patientson vitaminC who withdrewtheir consent did so because they wanted to take disulfiram; in addition, three initial recruits had withdrawnas soon as they heardthey had been assigned to vitamin C and were thus excluded from the trial population.) Tables 1-4 . Both treatment groups achieved a reduction in alcohol con sumption which by most estimates was greater with disulfiram, the treatment difference reaching statistical significance for values at 6 months (Table 1) . However, at the final assessmentthe numberof days since the last drink and alcohol consumption in the last month of the study revealed no significant treatment difference (Table 3) . The mean (s.d.) SADQ score at intake was similarin the two groups, and fellequally(disulfiram:intake 31.6(13.8)
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. At the end of the study the identity of the test treatment wasguessedcorrectlybytheindependent assessorfor65% of those followed up. This was not measuredat any of the earlier assessments. belief that an alcohol-reaction could occur. The correct test of the drug is a test of the â€˜¿ package', which includes emphasising the alcohol-reaction to the active group.
Although by the end of the study assessors were guessing the correct medication better than chance, the two measuresfor which their ratingssignificantly differed between the groups were scores summated (by computer) of ratings made over the six months, that is, abstinent days and units consumed.
In general there was little discrepancy in the six-month summated scores between the results as perceived by patient, informant and assessor, but despite having guessed accurately in some cases the assessors considered those on vitamin C to have achieved the same control of drinking as the disulfiram group. The explanation for this is not clear, but perhaps it slightly reduces the concern that bias influenced the assessors' ratings.
â€˜¿ P< 0.05.
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Estimates of alcohol consumption over the six month trial generally showed significant differences in favour of disulfiram. There was little difference in the final rating of â€˜¿ number of days since last drink', however, suggesting that some patients were perhaps using disulfiram to practise occasional limited drinking. By the end of the study there was no statistical difference in the last month's consumption, and this, together with the narrowing of the estimate of days since last drink (Table 3) 1984; O'Farrell & Bayog, 1986) . We also used a lower dose than in some of the American studies. In the study by Fuller et a! (1986), unsupervised disulfiram (250mg daily) plus counselling was associated with a reduction in the number of days on which alcohol was consumed, corroborated by relatives or friends.
However, this was demonstrated only in the one third of patients who provided all seven assessment interviews, and could not be seen in the remainder. It may be that supervision is necessary to the success of disulfiram treatment.
Treatment practices varied in the different centres
involved, and some centres appeared to have slightly better results than others. Even so, we suspect that our method was something some generalpractitioners could profitably arrange, with the spouse or practice nurse supervising treatment.
There were no medically serious disulfiram-alcohol reactions, and at the dose used in the study some patients did not experience a reaction after drinking.
Concerns about hepatic toxicity were not borne out. 
